Emergence of Morganellaceae Harboring blaIMP-27 Metalloenzyme in Canada
ABSTRACT
In 2018 to 2019, PCR for carbapenemases in routine Gram-negative isolates submitted to the National Microbiology Laboratory revealed an increase in IMP-type metalloenzyme-positive isolates, mostly among Morganellaceae. Whole-genome sequencing revealed that 23 Morganellaceae harbored blaIMP-27 within a chromosomal Tn7 element. Phylogenomics indicated diversity of isolates but also the presence of a few clonal isolates dispersed geographically. These isolates may be difficult to detect due to carbapenem susceptibility and false-negative results in phenotypic testing.
IMPORTANCE Over the last decade or so, the frequency of isolation of clinical carbapenemase-producing organisms (CPOs) has increased among health care-associated infections. This may seriously compromise antimicrobial therapy, as carbapenems are considered the last line of defense against these organisms. The ability of carbapenemases to hydrolyze most β-lactams in addition to the co-occurrence of mechanisms of resistance to other classes of antimicrobials in CPOs can leave few options for treating infections. The class B metalloenzymes are globally distributed carbapenemases, and the most commonly found include the NDM, VIM, and IMP types. Our study describes a sudden emergence of IMP-27-harboring Morganellaceae during 2018 to 2019 in Canada. There is a paucity of literature on IMP-27 isolates, and our data bolster the information on the genetic context, antimicrobial profiles, and phylogenomics of this group of CPOs.
INTRODUCTION
Carbapenemases, β-lactamases that hydrolyze carbapenem β-lactams, have been found globally among clinically significant members of the Enterobacterales (e.g., Escherichia coli, Klebsiella spp., Enterobacter spp., and Citrobacter spp.) and Pseudomonadales (e.g., Pseudomonas aeruginosa and Acinetobacter spp.) (1). The most prevalent carbapenemases are the so-called “big 5,” namely, KPC (class A), NDM, VIM, IMP (class B metallo-β-lactamases), and OXA-48 (class D). Though they are internationally distributed, some enzyme groups tend to be more prevalent in specific countries or areas (1, 2). The class B IMP enzymes, though found worldwide, tend to be more successfully established in Southeast Asia and the South Pacific regions and have occurred only sporadically in North America (2). Currently, 73 variants of IMP have been assigned (https://www.ncbi.nlm.nih.gov/pathogens/beta-lactamase-data-resources/). In Canada, the first IMP carbapenemase identified was blaIMP-7 from an outbreak of nosocomial P. aeruginosa isolated from 1995 to 1997 in a single region (3). The Canadian Nosocomial Infections Surveillance Program identified only two IMP producers among 615 carbapenemase-producing Enterobacterales collected from 2010 to 2016, an Enterobacter cloacae isolate harboring blaIMP-13 and an Acinetobacter pittii isolate harboring blaIMP-26 (4, 5). IMP-27 was first reported in 2011 from Proteus mirabilis PM185, isolated in 2009, with further studies determining that blaIMP-27 was on the chromosome in PM185, on an IncX8 plasmid and the chromosome in P. mirabilis PM187, and on a plasmid of unknown Inc type isolated from Providencia rettgeri PR1 (6–8). P. mirabilis GN855 harboring blaIMP-27 was reported from a patient in Ontario, Canada, in 2012 (9). Another study reported blaIMP-27 located on an IncQ1 plasmid found in multiple species of Enterobacterales, including P. mirabilis, Morganella morganii, and P. rettgeri, isolated from the environment of a swine operation in the United States (10).
RESULTS
Bacteria harboring blaIMP-27.
In 2018 and 2019 the National Microbiology Laboratory (NML) screened 2270 Gram-negative isolates by PCR for the most common carbapenemase gene groups, KPC, OXA-48, NDM, VIM, IMP, GES, and NMC/IMI. Twenty-eight isolates (1.2%) were positive by PCR for a blaIMP gene, including one P. rettgeri, 15 P. mirabilis, seven M. morganii, and five P. aeruginosa isolates. In 2017, of 242 P. aeruginosa and 30 Morganellaceae isolates received for routine carbapenemase PCR, four P. aeruginosa isolates and one M. morganii isolate (N17-03220) harbored an IMP gene. M. morganii N17-03220 was later found to be indistinguishable by pulsed-field gel electrophoresis (PFGE) from M. morganii N18-00103 received 56 days later (January 2018) and in fact was from the same patient, and it was no longer studied. Thus, there was a significant increase of Morganellaceae harboring blaIMP received by the NML after 2017. The 28 IMP-harboring isolates from 2018 to 2019 were from central (n = 9), western (n = 18), or eastern (n = 1) Canada and were isolated mainly from urine (n = 17), wounds (n = 4), or rectal swabs (n = 4). Whole-genome sequencing (WGS) analysis of all 2018–2019 isolates and P. mirabilis GN855 determined that all M. morganii isolates, 14 of the P. mirabilis isolates, and the P. rettgeri isolate harbored blaIMP-27, while among the P. aeruginosa isolates, one harbored blaIMP-7, one blaIMP-62, and three blaIMP-26. The blaIMP-27 gene could not be identified from the WGS data of one IMP PCR-positive P. mirabilis isolates and was presumed lost after subculture; therefore, this isolate was not further studied. Thus, among all the Morganellaceae received by the NML in 2018 to 2019 (n = 82) 26.8% (n = 22) were confirmed to harbor blaIMP-27.
Antimicrobial susceptibility and detection of blaIMP-27-harboring isolates.
Antimicrobial susceptibilities were determined for all IMP-harboring isolates as well as a few non-carbapenemase-producing organisms (CPOs) for comparative purposes (Table 1). As expected for Morganellaceae, most were intermediate (I) or resistant (R) to imipenem regardless of the presence/absence of IMP-27, confirming that this is not a suitable phenotype for indicating the possible presence of a carbapenemase. Gradient diffusion was poor for indicating IMP-27 presence, as most isolates were susceptible (S) to meropenem and ertapenem. By Sensititre testing, all IMP-27 P. mirabilis isolates and the P. rettgeri isolate were I or R to all carbapenems, while the non-CPOs were S to the three nonimipenem carbapenems. However, all of the M. morganii isolates were S to all nonimipenem carbapenems by Sensititre testing.
TABLE 1
a
Cell color indicates antimicrobial susceptibility category: yellow indicates resistance, green indicates intermediate or dose-dependent susceptibility (cefepime), and no color indicates susceptibility.
b
Etest values are as read, but for categorization, they are rounded up to the nearest doubling dilution. CZ, colonies in the zone.
c
Aztreonam, piperacillin-tazobactam, amikacin, and tobramycin are not listed as all isolates were susceptible.
d
Abbreviations: AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CTX, cefotaxime; DOR, doripenem; DOX, doxycycline; ETP, ertapenem; FEP, cefepime; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; TGC, tigecycline; TIM, ticarcillin-clavulanate; TOB, tobramycin; TZP, piperacillin-tazobactam; SXT, sulfamethoxazole-trimethoprim.
Full antibiograms were in congruence with the resistomes (Table 2). Among the phenotypic tests (Table 2), the modified carbapenem inactivation method (mCIM) test was 100% specific and sensitive for carbapenemase presence/absence. All mCIM-positive isolates were also positive by EDTA-modified CIM (eCIM), correctly indicating the presence of a class B enzyme. The β-Carba test was 100% sensitive and specific for M. morganii and P. rettgeri, but all IMP-27-producing P. mirabilis isolates were falsely negative. The Carba-NP and Neo-Rapid Carb test, which work on the same principle, performed poorly, and all IMP-27-producing P. mirabilis isolates and the P. rettgeri isolate were falsely negative. Among IMP-27 M. morganii isolates, results for the Carba-NP and Neo-Rapid Carb tests were variable, with some exhibiting false-negative, invalid, or weakly positive results.
TABLE 2
| Isolate | Resistomeb | Plasmid type | Phenotypic test for carbapenemase activityc | ||||
|---|---|---|---|---|---|---|---|
| mCIMd | β-Carba | Carba-NP | Neo-Rapid Carb | NG-Test CARBA 5e | |||
| P. mirabilis IMP-27 | |||||||
| GN855 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | NEG |
| N18-00201 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | NEG |
| N18-00931 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N18-02940 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N18-03414 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N18-04196 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-02040 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-02041 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-02665 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-02708 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-02786 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-03602 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-03729 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-04409 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| N19-05885 | blaIMP-27, aadA1, cat, tet(J) | No hits | POS | NEG | NEG | NEG | Not done |
| P. mirabilis non-CPO | |||||||
| N19-02761 | cat, tet(J) | No hits | NEG | NEG | NEG | NEG | NEG |
| N19-02763 | cat, tet(J) | No hits | NEG | NEG | NEG | NEG | Not done |
| N19-02764 | cat, tet(J) | No hits | NEG | NEG | NEG | NEG | Not done |
| M. morganii IMP-27 | |||||||
| N18-00103 | blaIMP-27, blaDHA-14, blaTEM-1B, aadA1, aadA2, aac(3)-Iid, aph(6)Id, aph(3′′)Ib, aph(3′)Ia, mph(A), catA1, tet(B), sul1, sul2, dfrA12 | IncQ1 | POS | POS | Invalid | wPOS | wPOS |
| N18-01877 | blaIMP-27, blaDHA-1, aadA1, catA2 | ColI (RGK), ColI440I | POS | POS | Invalid | POS | Not done |
| N18-02673 | blaIMP-27, blaDHA-1, aadA1, catA2, tet(B) | No hits | POS | POS | NEG | wPOS | Not done |
| N18-02869 | blaIMP-27, blaDHA-1, aadA1, catA2, tet(B) | No hits | POS | POS | NEG | wPOS | wPOS |
| N19-00225 | blaIMP-27, blaDHA-16, aadA1, catA2, tet(D), dfrA1 | No hits | POS | POS | NEG | wPOS | Not done |
| N19-00598 | blaIMP-27, blaDHA-1, aadA1, catA2, tet(B) | No hits | POS | POS | POS | POS | Not done |
| N19-05814 | blaIMP-27, blaDHA-1, aadA1, catA2, tet(B) | No hits | POS | POS | POS | POS | Not done |
| M. morganii non-CPO | |||||||
| N18-00856 | blaDHA-1, tet(B), catA2 | No hits | NEG | NEG | NEG | NEG | Not done |
| N18-03607 | blaDHA-1, tet(B), catA2 | IncX2, repA (FII) | NEG | NEG | NEG | NEG | NEG |
| P. rettgeri IMP-27: | |||||||
| N18-03642 | blaIMP-27, aadA1 | No hits | POS | POS | POS | NEG | Not done |
a
Resistome and plasmid types were determined by ResFinder and PlasmidFinder, respectively.
b
The sat-2 gene was not in the ResFinder database. The blaDHA gene is the intrinsic ampC gene of M. morganii.
c
POS, positive; NEG, negative. “Invalid” means that the no-meropenem control turned orange-yellow. “wPOS” means that an orange color was observed for the Carba-NP or NeoRapid Carb test or that a faint IMP band was observed in the NG-Test CARBA 5 test.
d
All mCIM-positive isolates were also positive in the eCIM test.
e
Immunochromatographic assay to detect KPC, OXA-48-like, VIM, IMP, and NDM enzymes.
We also tried the more expensive NG-Test CARBA 5 immunochromatographic assay on a small number of isolates, even though the package insert (ENO022CAR/Rev: 200131) does not list IMP-27 as one of the variants that can be detected by this test (Table 2). When the cells were obtained from tryptic soy agar (TSA)-blood plates (M. morganii) or Mueller-Hinton medium (P. mirabilis), all results were negative. Upon repeat testing with cells obtained from Mueller-Hinton containing 100 μg/ml ampicillin, a faint IMP-specific band was observed for the two IMP-27-harboring M. morganii isolates, though it was observed 5 to 10 min after the recommended test time of 15 min. The mCIM results indicate that IMP-27 is produced by all the blaIMP-27-harboring isolates in the study. Nonetheless, we determined specific activity against imipenem for the isolates tested by NG-Test CARBA 5 and confirmed imipenemase activity in the IMP-27-harboring isolates, though the activities can vary by 2- to 5-fold (Table 3).
TABLE 3
| Isolate | Sp act (μmol min−1 mg−1) |
|---|---|
| P. mirabilis | |
| GN 855 (IMP-27) | 70.1 ± 19.6 |
| N18-00201 (IMP-27) | 28.0 ± 5.1 |
| N18-02761 (non-CPO) | None detected |
| M. morganii | |
| N18-00103 (IMP-27) | 149.7 ± 22.1 |
| N18-02869 (IMP-27) | 70.7 ± 5.8 |
| N18-03607 (non-CPO) | None detected |
Together, the results indicate that P. mirabilis is likely recalcitrant to lysis/permeabilization in the non-mCIM phenotypic tests, all of which have a cell suspension/lysis solution. For the M. morganii isolates, although results indicate that some lysis does occur, it may be suboptimal, and this, combined with low IMP-27 levels for some isolates and/or technical issues, may account for poor results in the non-mCIM phenotypic tests.
blaIMP-27 is found within a Tn7 element located in the chromosome.
WGS analysis showed that the blaIMP-27 gene was located in the class 2 integron In2-71 (http://integrall.bio.ua.pt/?), which was integrated into a Tn7 element (Fig. 1). This structure, labeled Tn7[In2-71], was inserted into the chromosome of all isolates via the attTn7 site at the 3′ end of the glmS gene, the canonical bacterial Tn7 insertion site (11), and each element was flanked by direct repeats, indicating acquisition by transposition. Tn7[In2-71] elements were identified from the GenBank database (>99% identity) in P. mirabilis PM185 (accession no. NOWB01000038), P. rettgeri 106-1829X (accession no. KY847874), M. morganii 480-26370X (accession no. KY847873), and E. coli CFSAN051542 (accession no. CP020835). Sequence analysis divided the Tn7[In2-71] elements into two clades, A (n = 16) and B (n = 11), with the elements in clade A being >99.9% identical and the elements in clade B being 100% identical, but with the clades differing by 105 to 107 bp differences (Fig. 2). The vast majority of base pair differences were found in the tnsA-tnsB region indicating a region of recombination (data not shown). No plasmid replicons were identified in the P. mirabilis or the P. rettgeri isolates, whereas two M. morganii isolates harbored replicons (Table 2). Though IncQ1 plasmids have been found to harbor blaIMP-27 (10), the IncQ1 replicon in N18-00103 was found to be integrated into the chromosome and not linked to Tn7[In2-71].
FIG 1
FIG 2
Limited clonality revealed by core genome SNV analysis.
We carried out core genome SNV analysis on all P. mirabilis and all M. morganii to determine strain relatedness (Fig. 3A and B). Among the M. morganii isolates, 6 of 10 isolates are diverse, with the number of single nucleotide variants (SNVs) between them ranging from 83 to >14,000 (Fig. 3A). Four isolates clustered at 0 to 3 SNVs, but no strong epidemiological links could be uncovered between any of the four patients, though two isolates were from patients who had been in the same hospital but 470 days apart. The analysis of P. mirabilis, which included the U.S. IMP-27 isolates PM185 and PM187, showed that 10 isolates were diverse, differing by 752 to >12,800 SNVs from each other (Fig. 3B). However, the 11 P. mirabilis isolates harboring Tn7[In2-71]-B (Fig. 2) clustered together at 0 to 13 SNVs or 1 to 15 SNVs when reanalyzed separately with an internal reference and, hence, a larger core genome. Anonymized patient facilities were available for some isolates, indicating some common facilities, but the limited data make inferring direct transmission events unfeasible. Nonetheless, this cluster of closely related isolates can be postulated to have derived from a common ancestor that has spread to multiple locations in western Canada.
FIG 3
DISCUSSION
Morganellaceae isolates harboring blaIMP-27 have emerged in Canada since 2018. These isolates may be difficult to detect as CPOs, as they can exhibit susceptibility to carbapenems depending on which susceptibility testing method is used. The mCIM detected carbapenemase production or lack thereof among all study isolates, as did the β-Carba test for the M. morganii and P. rettgeri isolates. Though blaIMP-27 was exclusively chromosomally located here, its dissemination may be facilitated by being harbored within a mobile Tn7 transposon. Isolates were diverse but phylogenomics revealed clones harboring blaIMP-27 have dispersed in Canada. The major limitation of this study was that isolates were voluntarily submitted to the NML, and thus, the prevalence of blaIMP-27 isolates may be underestimated. In addition, due to blaIMP family sequence variation, in-house primers and some commercial assays may yield false-negative results (12).
MATERIALS AND METHODS
Bacterial isolates.
The bacteria in this study were from routine isolates voluntarily sent to the NML for carbapenemase PCR. Typically, organisms are sent because of a suspicion of carbapenemase production due to reduced susceptibility/resistance to a carbapenem and/or a positive result of a phenotypic method that indicates carbapenemase production. For the isolates that test positive, the PCR results are reported, and the carbapenemase gene is not sequenced unless by special request.
Antimicrobial susceptibilities and phenotypic carbapenemase detection.
Antimicrobial susceptibilities were carried out by Etest (bioMérieux) and Sensititre GNX2F plates (Thermo Fisher Scientific, Toronto, ON, Canada). Categorical interpretations were done using CLSI (13) or FDA guidelines (tigecycline). The β-Carba test (Bio-Rad Laboratories, Mississauga, ON, Canada), Neo-Rapid Carb test (Roscoe Diagnostica, Taastrup, Denmark), and NG-Test CARBA 5 (NG Biotech, Guipry, France) were carried out per the manufacturer’s instructions. The Carba-NP, mCIM, and eCIM tests were carried out as described elsewhere (13).
Carbapenemase multiplex PCR.
The carbapenemase multiplex PCR was as previously described (4) except with two updated primers, IMP-F2 (5′-CTTGAMGARGGYGTTTATGTTCATAC), which pairs with IMP-2, and IMI-Dr (5′-TCATTTGCMGTACCGTATGC), which pairs with IMI-A.
Sequencing and bioinformatics.
Whole-genome sequencing (WGS) was carried out on all isolates by NextSeq (Illumina Inc., San Diego, CA), with two isolates (M. morganii N18-00103 and P. mirabilis N18-00201) additionally sequenced by Nanopore technology (Oxford Nanopore Technologies, Oxford, UK). Read assembly was carried out using Unicycler v0.4.4 (14). Single nucleotide variant (SNV) analysis was carried out using the SNVPhyl Pipeline (15). Assemblies were analyzed by the ResFinder and PlasmidFinder tools at the Center of Genomic Epidemiology website (http://www.genomicepidemiology.org).
Data availability.
Nucleotide sequences and WGS reads have been deposited in NCBI BioProject PRJNA603518. The complete closed genomes of P. mirabilis N18-00201 and M. morganii N18-00103 and the draft genome of P. rettgeri N18-02642 have been assigned accession no. CP048404, CP048275, and JAAOIA000000000, respectively. The sequence of Tn7[In2-71] from N18-02940 has been assigned accession no. MT226801.
ACKNOWLEDGMENTS
We gratefully acknowledge the expert technical assistance of Ken Fakharuddin and Romeo Hizon as well as the staff of the Genomics Core Facility of the NML.
REFERENCES
1.
Nordmann P, Poirel L. 2014. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830.
2.
Matsumura Y, Peirano G, Motyl MR, Adams MD, Chen L, Kreiswirth B, DeVinney R, Pitout JD. 2017. Global molecular epidemiology of IMP-producing Enterobacteriaceae. Antimicrob Agents Chemother 61:e02729-16.
3.
Gibb AP, Tribuddharat C, Moore RA, Louie TJ, Krulicki W, Livermore DM, Palepou M-FI, Woodford N. 2002. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7. Antimicrob Agents Chemother 46:255–258.
4.
Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, Boyd DA, Embree J, Katz K, Kibsey P, Simor AE, Taylor G, Turgeon N, Langley J, Gravel D, Amaratunga K, Mulvey MR. 2016. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014. Antimicrob Agents Chemother 60:6787–6794.
5.
Boyd DA, Mataseje LF, Pelude L, Mitchell R, Bryce E, Roscoe D, Embree J, Katz K, Kibsey P, Lavallee C, Simor AE, Taylor G, Turgeon N, Langley JM, Amaratunga K, Mulvey MR, Wong A, McGeer A, Simor A, Lee B, Frenette C, Ellis C, Lavallee C, Mertz D, Bryce E, Henderson E, Taylor G, German G, Davis I, de Heer J, Minion J, Embree J, Langley J, Srigley J, Embil J, Vayalumkal J, Suh K, Katz K, Johnston L, Lefebvre M-A, John M, Blackburn MM, Bridger N, Turgeon N, Thampi N, Kibsey P, Stagg P, Richardson S, Hota S, Pelletier S, members of the Canadian Nosocomial Infection Surveillance Program, et al. 2019. Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010–16. J Antimicrob Chemother 74:315–320.
6.
Moulds NM, Thomson KS, Hanson ND. 2011. IMP-27, a novel metallo-β-lactamase (MBL) associated with a class II integron identified in an isolate of Proteus mirabilis, abstr C1-1212. Abstr 51st Intersci Conf Antimicrob Agents Chemother.
7.
Dixon N, Fowler RC, Yoshizumi A, Horlyama T, Ishii Y, Harrison L, Geyer CN, Moland ES, Thomson K, Hanson ND. 2016. IMP-27, a unique metallo-β-lactamase identified in geographically distinct isolates of Proteus mirabilis. Antimicrob Agents Chemother 60:6418–6421.
8.
Potter RF, Wallace MA, McMullen AR, Prusa J, Stallings CL, Burnham CAD, Dantas G. 2018. blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri. Clin Microbiol Infect 24:1019.E5–1019.E8.
9.
Tiget N, Siebert H, MacNeill M, Rawte P, Farrell DJ, Low DE, Patel SN, Melano RG. 2012. Detection of IMP-27 metallo-β-lactamase in Proteus mirabilis, ON, Canada, abstr C2-090. Abstr 52st Intersci Conf Antimicrob Agents Chemother.
10.
Mollenkopf DF, Stull JW, Mathys DA, Bowman AS, Feicht SM, Grooters SV, Daniels JB, Wittum TE. 2017. Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agents Chemother 61:e01298-16.
11.
Peters JE. 2014. Tn7. Microbiol Spectr 2:MDNA3-0010-2014.
12.
Lowe CF, Matic N, Champagne S, Romney MG, Leung V, Ritchie G. 2020. The Brief Case: IMP, the uncommonly common carbapenemase. J Clin Microbiol 58:e01094-19.
13.
Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing: M100, 30th ed. CLSI, Wayne, PA, USA.
14.
Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595.
15.
Petkau A, Mabon P, Sieffert C, Knox NC, Cabral J, Iskander M, Iskander M, Weedmark K, Zaheer R, Katz LS, Nadon C, Reimer A, Taboada E, Beiko RG, Hsiao W, Brinkman F, Graham M, Van Domselaar G. 2017. SNVPhyl: a single nucleotide variant phylogenomics pipeline for microbial genomic epidemiology. Microb Genom 3:e000116.
Information & Contributors
Information
Published In
mSphere
Volume 6 • Number 3 • 30 June 2021
eLocator: 10.1128/msphere.00048-21
Editor: Patricia A. Bradford, Antimicrobial Development Specialists, LLC
PubMed: 34011680
Copyright
© 2021 Crown. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
History
Received: 15 January 2021
Accepted: 27 April 2021
Published online: 19 May 2021
Keywords
Contributors
Editor
Patricia A. Bradford
Editor
Antimicrobial Development Specialists, LLC
Metrics & Citations
Metrics
Note:
- For recently published articles, the TOTAL download count will appear as zero until a new month starts.
- There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
- Citation counts come from the Crossref Cited by service.
Citations
Citation
2021.
Emergence of Morganellaceae Harboring blaIMP-27 Metalloenzyme in Canada. mSphere
6:10.1128/msphere.00048-21.
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.